Diabetes: precision approach will improve outcomes, says research director
“If we can understand as early as possible the person’s risk of progression then we can start to tailor prevention strategies if we get in their early enough—or ensure that people we know are going to progress rapidly receive early, aggressive treatment.” Looking to the future, Robertson said, “The...
Saved in:
| Published in: | BMJ (Online) 2019-01, Vol.364, p.l186-l186 |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | eng |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | “If we can understand as early as possible the person’s risk of progression then we can start to tailor prevention strategies if we get in their early enough—or ensure that people we know are going to progress rapidly receive early, aggressive treatment.” Looking to the future, Robertson said, “The aim is to get a much more accurate diagnosis of diabetes, based on a patient’s history, genetics, and other emerging biomarkers, so we are much clearer on the potential risk of progression and what we can do that will be most effective for each patient.” Robertson was speaking at a briefing hosted by University College London, before giving the Royal Pharmaceutical Society and University College London School of Pharmacy New Year Lecture on the prevention and treatment of diabetes, which is funded by the Communications International Group, MSD, and Lilly. 1 Ahlqvist E Storm P Käräjämäki A. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. |
|---|---|
| ISSN: | 0959-8138 1756-1833 |